Intravitreal triamcinolone acetonide for the management of diabetic papillopathy

PURPOSE: To present a case of severe drop in vision in both eyes caused by diabetic papillopathy that was treated with an intravitreal injection of triamcinolone acetonide. DESIGN: Interventional case report. METHODS: A diabetic patient with bilateral diabetic papa illopathy and drop in vision received sequential intravit, real triamcinolone acetonide injections to both eyes. RESULTS: Within 2 weeks of intravitreal injection, vision improved from counting fingers at 1 m to 20/50 OS, and from counting fingers at 4 m to 20/40 OD. This improve. ment was accompanied by resolution of disk swelling and macular edema. Vision remained stable in both eyes at 20/40 for 8 months of follow-up. No elevation of intraocular pressure beyond 21 mm Hg was noted at any time. CONCLUSION: Diabetic papillopathy with severe drop in vision can be treated with intravitreal triamcinolone acetonide injection. @ 2004 by Elsevier Inc. All rights reserved.